Sponsored Link:

Page Analysis

Sponsored Link:


496 ratings.827 user reviews.

Web page information

  1. Keywords hit in search results
    acquisition africa agreement amylin announced antibiotic approach approaches ardea asthma astrazeneca based billion biologics biopharmaceutical biosciences british cancellation chairman change closed company completed contribution court creating developing development diabetes difference dividend drugs efforts encyclopedia european finds focus formulation friday further glaxosmithkline global headquartered healthcare heart highest improve innovative invalid kingdom licensing lives london meaningful medicines middle multinational north novartis ordinary patent patients pence people pfizer pharmaceutical pharmaceuticals pioneering purchased recently research reuters rigel right rival seroquel share shares slovakia spain specialist stock sweden swedish switzerland telegraph terms thursday today treatment turkey understood united valuing vision wednesday wikipedia world xr® yield
  2. Search Engine Recommended Keywords
    AstraZeneca Patient Assistance Program, AstraZeneca Benefits, AstraZeneca Careers, AstraZeneca Seroquel, AstraZeneca Products, AstraZeneca Nexium, AstraZeneca Samples, AstraZeneca Drugs,
AstraZeneca United Kingdom
Our focus is on developing new medicines that make a meaningful difference to patients’ lives, and the UK is right at the heart of our efforts to do that.
AstraZeneca - a global research-based biopharmaceutical company
Slovakia; Spain; Sweden; Switzerland; United Kingdom; Middle East & North Africa. Turkey ... As a global biopharmaceutical company, AstraZeneca has a key contribution to make ...
AstraZeneca - Wikipedia, the free encyclopedia
AstraZeneca plc (LSE: AZN, OMX: AZN) is a British -Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world ...
AstraZeneca United Kingdom
We want to work with people who share our vision of creating new medicines and innovative approaches to healthcare that improve people’s lives.
AstraZeneca $4bn approach for diabetes specialist Amylin - Telegraph
AstraZeneca $4bn approach for diabetes specialist Amylin AstraZeneca is understood to have made a $4bn (£2.6bn) takeover approach for Amylin, a US rival that ...
AstraZeneca - UK court finds SEROQUEL XR® formulation patent invalid
UK court finds SEROQUEL XR® formulation patent invalid ... AstraZeneca today announced that the High Court in the UK has rendered its opinion on the formulation ...
AstraZeneca Jobs - Find your perfect role at AstraZeneca and help ...
A note about work permits in the UK. AstraZeneca is an equal opportunity employer and we encourage diversity in the workplace. Current British and European Laws state that ...
AstraZeneca braced for change under new chairman | Reuters
LONDON (Reuters) - AstraZeneca's new chairman took the helm on Friday and said the troubled drugmaker faced "a period of significant change". Leif ...
AstraZeneca - Inspiring Careers
Sales Representatives sell AstraZeneca medicines to medical professionals such as doctors. The job involves a lot of travel, both in the UK and abroad.
BBC News - AstraZeneca to cut a further 7,300 jobs
Anglo-Swedish drugs maker AstraZeneca has announced a further 7,300 job cuts over the next two years as part of a new restructuring programme. The GMB ...

News Results

AstraZeneca Buys Ardea Biosciences
AstraZeneca plc (AZN) recently announced that it has completed the acquisition of Ardea Biosciences, Inc. for approximately $1.26 billion or $32 per share. Both AstraZeneca and Ardea’s boards unanimously supported the merger. Ardea’s ...
Yahoo Finance
AstraZeneca, RIGL in Licensing Deal
AstraZeneca (AZN) and Rigel Pharmaceuticals, Inc. (RIGL) recently announced that they have entered into a licensing agreement for Rigel’s asthma candidate, R256. Per the terms of the agreement, AstraZeneca will make an upfront payment of $1 ...
Yahoo Finance
AstraZeneca, Rigel to Develop Asthma Treatment
AstraZeneca PLC (AZN, AZN.LN) has inked an agreement with Rigel Pharmaceuticals Inc. (RIGL) for the development and commercialization of an investigational asthma treatment. The treatment, R256, has been shown in preclinical studies to reduce ...
AstraZeneca completes $1.26B Ardea purchase
NEW YORK — AstraZeneca PLC said Wednesday that it completed its $1.26 billion acquisition of gout drug developer Ardea Biosciences Inc. AstraZeneca agreed to buy Ardea in April for $32 per share, a 54 percent premium to the stock's closing ...
GlaxoSmithKline and AstraZeneca launch pioneering approach to antibiotic research
It was announced today that GlaxoSmithKline and AstraZeneca have launched a pioneering approach to antibiotic research in Europe to attempt to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of ...
Transworld News
AstraZeneca Buys Back 80,000 Own Shares to Cancel/2770P
AstraZeneca PLC (AZN.LN) said Monday it purchased for cancellation 80,000 of its own ordinary shares at a price of 2770 pence per share. -Shares at 0830 GMT down 23 pence, or 0.8%, at 2,748 pence valuing the company at GBP34.6 billion.
AstraZeneca Ranks the Highest in Terms of Dividend Yield in the Pharmaceuticals Industry (AZN, LLY, NVS)
Dividends can enhance returns for investors seeking income in addition to capital gains. AstraZeneca (NYSE:AZN) is highest with a dividend yield of 9.0%. AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and ...
Financial News Network Online
UPDATE 3-Novartis, Astra win EU drug okays; Pfizer loses out
LONDON, June 22 (Reuters) - Novartis and AstraZeneca won recommendations for important new drugs from European regulators on Friday, while rival Pfizer lost out. The European Medicines Agency said its Committee for Medicinal Products for Human ...
AstraZeneca Buys Back 484,970 Shares/2749P
LONDON--AstraZeneca PLC (>> AstraZeneca plc) said Tuesday that it purchased for cancellation 484,970 of its ordinary shares at 2749 pence per share on June 25. Shares at 0730 GMT down 6 pence, or 0.24%, at 2738.5 pence valuing the company at 34.6 billion pounds.
4-traders (press release)
AstraZeneca (AZN) Showing Bullish Technicals With Support At $42.54
Thursday, June 14, 2012... AstraZeneca (NYSE:AZN) closed Wednesday's downbeat trading session at $41.76. In the past year, the stock has hit a 52-week low of $39.72 and 52-week..... Friday, June 08, 2012... AstraZeneca Plc (NYSE: AZN) closed Thursday's ...
Market Intelligence Center
No Coupons found for this website.

500 characters left

Your Review: (5 out of 5)
refresh captcha

Server Information
IP Address:
Server:Footprint Distributor V4.8
Site Disclaimer:

All trademarks are the property of their respective owners. The facts, figures, reviews, records, stats, and other data presented on this page is for suggestion and information purposes only. PageGlimpse.com is not responsible for any incorrect or incomplete information. PageGlimpse.com does not take responsibility for any user-reviews of websites inside its resource and reserves the right to keep or remove those. It is highly recommended that you review all the data for accuracy.